European Oral Drug Delivery Market Research Report
- Report Code: OR 1002
- Publish Date: Upcoming
The European oral drug delivery market, mainly driven by ‘patent cliffs’, increased incidence of chronic diseases, increasing competition, improving patient compliance, reformulation and repositioning of drugs using advanced oral delivery systems, and huge investments made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies, was valued at $16.9 billion in 2013 and is expected to reach $24.6 billion by 2018, at a CAGR of 7.7% from 2013 to 2018.
The report analyzes the market in terms of segments, such as controlled release, and ODT & taste masking, among others.
Europe holds the second position, in terms of value, in the global pharmaceutical market. The European pharmaceutical market was valued at $228 billion in 2011, accounting for 26.8% of the global market. The industry invested nearly $36500 million in R&D in 2011, provided direct employment to 660,000 Europeans, and generated three to four times more employment indirectly. However, the pharmaceutical markets in the five major European countries, namely, Germany, France, the U.K., Italy, and Spain, grew at an average rate of 2.6% in 2011, due to the overall current grim economic conditions in Europe and the increasing competition from emerging nations.
The report also provides an extensive competitive landscaping of the leading companies operating in this market. The main companies in the market include Aptalis Pharmaceutical Technologies, Sky Pharma PLC, Tapemark, Baxter International Inc., and Hovione Ltd., among others. Furthermore, segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in the report.
Customization Options:
Along with the market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix, which gives a detailed comparison of product portfolio of each company, mapped at country and sub-segment levels
- End-user adoption rate analysis of the products (segment-wise and country-wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Pharmacists’ Forum
- Fast turn-around analysis of pharmacists’ responses to market events and trends
- Pharmacists’ opinions about products from different companies
- Pharmacists’ qualitative inputs on epidemiology data
- Pattern analysis of usage of drugs by physicians
Brand/Product Perception Matrix
- A comprehensive study of customers’ perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- An analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
